Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Jordan Pharmaceutical Manufacturing Company (JPM) is a leading pharmaceutical enterprise headquartered in Amman, Jordan, dedicated to the development, manufacturing, and distribution of high-quality generic and value-added medicines. Since its inception in 1978, JPM has established a robust presence in the Middle East and North Africa (MENA) region and beyond, exporting its products to more than 30 countries. The company’s extensive product portfolio covers a wide range of therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, and respiratory health. JPM is notable for its significant investment in research and development, supported by specialized subsidiaries like AraGen for biotechnology and Suwagh for advanced drug delivery technologies. As a publicly traded company on the Amman Stock Exchange, JPM continues to expand its global footprint through strategic partnerships and a commitment to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The JPM Company.